U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07472777) titled 'Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis' on March 06.
Brief Summary: Through a retrospective cohort study method, the influence of Gu-Lu Er-Xian Decoction with modified formula on the long-term therapeutic effect of patients with myasthenia gravis was analyzed, and the related factors affecting recurrence were also explored.
Study Start Date: Jan. 01, 2024
Study Type: OBSERVATIONAL
Condition:
Myasthenia Gravis (MG)
Recruitment Status: COMPLETED
Sponsor: Beijing University of Chinese Medicine
Information provided by (Responsible Party): Ruge Liu, Beijing University of Chinese Medicine
Published...